DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $9,570,480 | +394.3% | 39,877 | +419.1% | 0.21% | +452.6% |
Q1 2023 | $1,936,171 | -72.5% | 7,682 | -72.3% | 0.04% | -47.9% |
Q2 2022 | $7,030,000 | -33.1% | 27,729 | -22.7% | 0.07% | -34.8% |
Q1 2022 | $10,516,000 | +9.6% | 35,852 | +22.9% | 0.11% | +16.7% |
Q4 2021 | $9,598,000 | +598.0% | 29,173 | +469.5% | 0.10% | +638.5% |
Q2 2021 | $1,375,000 | +22.3% | 5,123 | +2.6% | 0.01% | +18.2% |
Q1 2021 | $1,124,000 | -59.0% | 4,992 | -59.5% | 0.01% | -71.8% |
Q4 2020 | $2,741,000 | +592.2% | 12,339 | +311.3% | 0.04% | +290.0% |
Q1 2019 | $396,000 | -43.6% | 3,000 | -57.9% | 0.01% | -9.1% |
Q2 2018 | $702,000 | +98.3% | 7,118 | +96.7% | 0.01% | +83.3% |
Q1 2018 | $354,000 | +41.6% | 3,618 | +34.5% | 0.01% | +50.0% |
Q4 2017 | $250,000 | -85.4% | 2,689 | -86.8% | 0.00% | -84.6% |
Q2 2017 | $1,713,000 | +102.5% | 20,297 | +105.2% | 0.03% | +116.7% |
Q1 2017 | $846,000 | -58.1% | 9,889 | -61.6% | 0.01% | -58.6% |
Q3 2016 | $2,018,000 | -86.5% | 25,745 | -82.6% | 0.03% | -88.3% |
Q2 2016 | $14,956,000 | +11.8% | 148,081 | +5.0% | 0.25% | +20.4% |
Q1 2016 | $13,383,000 | +605.1% | 141,083 | +415.1% | 0.21% | +564.5% |
Q3 2013 | $1,898,000 | – | 27,392 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |